What is the equity of Ono Pharmaceutical Co this year?
Ono Pharmaceutical Co has equity of 792.96 B JPY this year.
In 2024, Ono Pharmaceutical Co's equity was 792.96 B JPY, a 20.9% increase from the 655.91 B JPY equity in the previous year.
Ono Pharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Ono Pharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating Ono Pharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Ono Pharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in Ono Pharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Ono Pharmaceutical Co has equity of 792.96 B JPY this year.
The equity of Ono Pharmaceutical Co has increased/decreased by 20.9% increased compared to the previous year.
A high equity is advantageous for investors of Ono Pharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of Ono Pharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of Ono Pharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of Ono Pharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of Ono Pharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.
The equity of Ono Pharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, Ono Pharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, Ono Pharmaceutical Co paid a dividend of 80 JPY . This corresponds to a dividend yield of about 4.19 %. For the coming 12 months, Ono Pharmaceutical Co is expected to pay a dividend of 86.14 JPY.
The current dividend yield of Ono Pharmaceutical Co is 4.19 %.
Ono Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
Ono Pharmaceutical Co paid dividends every year for the past 23 years.
For the upcoming 12 months, dividends amounting to 86.14 JPY are expected. This corresponds to a dividend yield of 4.51 %.
Ono Pharmaceutical Co is assigned to the 'Health' sector.
To receive the latest dividend of Ono Pharmaceutical Co from 12/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
The last dividend was paid out on 12/1/2024.
In the year 2023, Ono Pharmaceutical Co distributed 77 JPY as dividends.
The dividends of Ono Pharmaceutical Co are distributed in JPY.
Our stock analysis for Ono Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ono Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.